HUNAN HANSEN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.12 CNY | +2.34% |
|
+6.07% | -9.73% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 916M 127M | Sales 2023 | 956M 132M | Capitalization | 3.41B 472M |
|---|---|---|---|---|---|
| Net income 2022 | 168M 23.26M | Net income 2023 | 205M 28.38M | EV / Sales 2022 | 3.19 x |
| Net cash position 2022 | 161M 22.3M | Net cash position 2023 | 160M 22.13M | EV / Sales 2023 | 3.4 x |
| P/E ratio 2022 |
18.4
x | P/E ratio 2023 |
16.6
x | Employees | 1,533 |
| Yield 2022 |
4.89% | Yield 2023 |
-
| Free-Float | 46.71% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.34% | ||
| 1 week | +6.07% | ||
| Current month | +6.07% | ||
| 1 month | +7.18% | ||
| 3 months | +30.21% | ||
| 6 months | -11.18% | ||
| Current year | -9.73% |
1 week
5.83
6.19
1 month
4.806.19
Current year
4.087.07
1 year
4.087.38
3 years
4.089.58
5 years
4.0813.50
10 years
4.0823.82
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Qing Liu
CEO | Chief Executive Officer | 60 | 08-01-19 |
Jiang Hong Dai
DFI | Director of Finance/CFO | 54 | 20-05-24 |
Sai Cheng Liu
CHM | Chairman | 62 | 20-05-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zheng Qing Liu
CEO | Chief Executive Officer | 60 | 08-01-19 |
Ping Zhan
BRD | Director/Board Member | 59 | 20-05-18 |
Ren Hui Fu
BRD | Director/Board Member | 54 | 08-01-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 6.12 | +2.34% | 14,722,540 |
| 24-05-08 | 5.98 | +0.50% | 13,554,730 |
| 24-05-07 | 5.95 | -1.82% | 18,196,000 |
| 24-05-06 | 6.06 | +5.03% | 20,842,340 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes
Hunan Hansen Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of traditional Chinese medicine preparations, chemical medicine and medical preparations. The Companyâs main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency, among others. The Company mainly distributes its products in domestic markets.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -9.73% | 427M | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +16.34% | 239B | |
| +6.68% | 204B | |
| -9.08% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- 002412 Stock